TMS Co., Ltd. (JP:4891) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TMS Co., Ltd., a biopharmaceutical company focusing on transformative medicines, will attend a corporate access event during the J.P. Morgan Annual Healthcare Conference in San Francisco in January 2025. The company is advancing its pipeline which includes treatments for acute ischemic stroke and other serious conditions.
For further insights into JP:4891 stock, check out TipRanks’ Stock Analysis page.